What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Insulin
Jerry P. Palmer spends much of his time researching Internal medicine, Diabetes mellitus, Insulin, Endocrinology and Type 1 diabetes.
His research in Internal medicine intersects with topics in Gastroenterology, Placebo and Diabetic retinopathy.
Jerry P. Palmer interconnects Autoantibody, Autoimmune disease, Autoimmunity and Immunology in the investigation of issues within Diabetes mellitus.
His work carried out in the field of Insulin brings together such families of science as Percentile, Predictive value of tests and Antibody.
His studies deal with areas such as Glutamate decarboxylase and Hazard ratio as well as Endocrinology.
His Type 1 diabetes research incorporates elements of Clinical trial, Oncology, Retinopathy, Research design and Immunopathology.
His most cited work include:
- Follow-up Report on the Diagnosis of Diabetes Mellitus (3225 citations)
- Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function (1232 citations)
- Insulin antibodies in insulin-dependent diabetics before insulin treatment (942 citations)
What are the main themes of his work throughout his whole career to date?
Jerry P. Palmer mainly investigates Internal medicine, Diabetes mellitus, Endocrinology, Type 1 diabetes and Insulin.
Jerry P. Palmer has researched Internal medicine in several fields, including Gastroenterology and Autoantibody.
The concepts of his Diabetes mellitus study are interwoven with issues in Antibody, Immunology and Immunopathology.
He combines subjects such as Glutamate decarboxylase and Cell with his study of Endocrinology.
His Type 1 diabetes study combines topics in areas such as Clinical trial, Research design, Disease, Prospective cohort study and Oral glucose tolerance.
The various areas that he examines in his Insulin study include Stimulation, In vivo and Risk factor.
He most often published in these fields:
- Internal medicine (80.27%)
- Diabetes mellitus (65.31%)
- Endocrinology (60.88%)
What were the highlights of his more recent work (between 2011-2021)?
- Type 1 diabetes (53.06%)
- Internal medicine (80.27%)
- Diabetes mellitus (65.31%)
In recent papers he was focusing on the following fields of study:
His main research concerns Type 1 diabetes, Internal medicine, Diabetes mellitus, Endocrinology and Immunology.
His Type 1 diabetes research integrates issues from Clinical trial, Autoimmune disease, Disease, Cumulative incidence and Oral glucose tolerance.
His Internal medicine study combines topics in areas such as Gastroenterology and Autoantibody.
As part of one scientific family, he deals mainly with the area of Autoantibody, narrowing it down to issues related to the Proportional hazards model, and often Proband.
In the field of Diabetes mellitus, his study on Type 2 diabetes overlaps with subjects such as Trial Type.
His Endocrinology study integrates concerns from other disciplines, such as Placebo and Natural history.
Between 2011 and 2021, his most popular works were:
- GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus (224 citations)
- Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis (204 citations)
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data (203 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Disease
His primary scientific interests are in Diabetes mellitus, Type 1 diabetes, Internal medicine, Immunology and Endocrinology.
His Diabetes mellitus research incorporates themes from Young adult, Cell, Natural history and Framingham Risk Score.
His studies deal with areas such as Hazard ratio, Natural history study, Gastroenterology and Insulin resistance as well as Type 1 diabetes.
His Internal medicine research incorporates elements of Research design and Autoantibody.
The study incorporates disciplines such as Glutamate decarboxylase and Placebo in addition to Endocrinology.
His Autoimmunity research includes themes of Immunofluorescence, Innate immune system, Type 2 diabetes and Islet.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
